IP Library Granted Patent US 7,498,136
Granted Patent B2
US 7,498,136 · App. 11/376,952 · Granted Mar 3, 2009

Methods for detecting multiple species and subspecies of

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,498,136
App. No.
11/376,952
Granted
Mar 3, 2009
Kind
B2
Abstract

Disclosed are methods, kits, and other components for detecting multiple nucleic acids in a sample. The methods and kits may be useful for detecting Neisseria in a sample. In some embodiments, the methods include (a) reacting a mixture that includes (i) nucleic acid isolated from the sample; (ii) at least a first specific primer capable of being used to amplify specifically nucleic acid of Neisseria gonorrhea ; (iii) at least a second specific primer capable of being used to amplify specifically nucleic acid of a non-gonococcal species of Neisseria ; (iv) at least a universal primer capable of being used to amplify specifically nucleic acid of Neisseria gonorrhea and nucleic acid of a non-gonococcal species of Neisseria ; and (b) amplifying and detecting nucleic acid of at least one of Neisseria gonorrhea and a non-gonococcal species of Neisseria . The disclosed kits may include one or more components for performing the disclosed methods.

Claims (25)

1. A method for detecting Neisseria in a sample comprising:

(a) reacting a mixture comprising:

(i) nucleic acid isolated from the sample;

(ii) at least a first specific primer capable of being used to amplify nucleic acid of Neisseria gonorrhea , wherein the sequence of the first primer consists of SEQ ID NO: 1;

(iii) at least a second specific primer capable of being used to amplify nucleic acid of at least one non-gonococcal species of Neisseria , wherein the sequence of the second primer consists of SEQ ID NO: 2;

wherein at least one of the first specific primer and the second specific primer comprise a first non-natural nucleotide base and a label;

(iv) at least a universal primer capable of being used to amplify nucleic acid of Neisseria gonorrhea and nucleic acid of the at least one non-gonococcal species of Neisseria;

(v) a second non-natural nucleotide base conjugated to a quencher;

(b) performing an amplification reaction with the primers of step (a) to produce amplification products of nucleic acid of at least one of Neisseria gonorrhea and the at least one non-gonococcal species of Neisseria , if present, wherein the second non-natural nucleotide base is incorporated opposite the first non-natural nucleotide base; and

(c) detecting the amplification products by observing a signal from the label, wherein the signal may be quenched upon incorporation of the second non-natural nucleotide base into the amplification products.

2. The method of claim 1 , wherein the non-gonococcal species of Neisseria is selected from the group consisting of Neisseria subflava, Neisseria cinerea, Neisseria perflava and combinations thereof.

3. The method of claim 1 , wherein the label comprises a fluorophore.

4. The method of claim 3 , wherein the first specific primer comprises the first non-natural nucleotide base conjugated to a first fluorophore and the second specific primer includes another non-natural nucleotide base conjugated to a second fluorophore which is different than the first fluorophore.

5. The method of claim 1 , wherein the first non-natural nucleotide base comprises iC or iG.

6. The method of claim 4 , wherein the second non-natural nucleotide base is conjugated to a fluorescence quencher.

7. The method of claim 6 , wherein the second non-natural nucleotide base is conjugated to a fluorescence quencher that is capable of quenching the first fluorophore and the second fluorophore.

8. The method of claim 3 , wherein detecting comprises observing a change in fluorescence of the fluorophore.

9. The method of claim 8 , wherein the change in fluorescence is a decrease in fluorescence.

10. The method of claim 1 , wherein the amplified nucleic acid is detected during amplification.

11. The method of claim 1 wherein the amplified nucleic acid is detected after amplification.

12. The method of claim 1 , wherein at least one of the first specific primer, the second specific primer, and the universal primer is capable of specifically hybridizing to 16S ribosomal nucleic acid of Neisseria.

13. The method of claim 12 , wherein the first specific primer, the second specific primer, and the universal primer are capable of specifically hybridizing to 16S ribosomal nucleic acid of Neisseria.

14. The method of claim 1 , wherein the universal primer comprises SEQ ID NO: 3.

15. The method of claim 1 , wherein the reaction mixture further comprises amplification reagents.

16. The method of claim 1 , wherein the second non-natural nucleotide base is complementary to the first non-natural nucleotide base.

Assignments (2)
MERGER Recorded Jun 21, 2012
From: ERAGEN BIOSCIENCES, INC.
To: LUMINEX CORPORATION
Reel/Frame 028420/0945 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2006
From: JOHNSON, SCOTT C.
To: ERAGEN BIOSCIENCES, INC.
Reel/Frame 017697/0255 →